(Q64987425)
Statements
A novel thromboxane receptor antagonist and synthase inhibitor, BM-573, reduces development and progression of atherosclerosis in LDL receptor deficient mice. (English)
Tillmann Cyrus
Yuemang Yao
Tao Ding
Jean Michel Dogné
Domenico Praticò
19 January 2007
561
1-3
105-111